Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16250375 | 0.95 | TSHR (0.33) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL2482893 | 0.92 | TSHR (0.32) | TSHRMAPK1 | |
| SCHEMBL6285483 | 0.89 | TSHR (0.36) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL27754281 | 0.89 | TSHR (0.32) | TSHRMAPK1 | |
| SCHEMBL11281488 | 0.88 | TSHR (0.30) | TSHR | |
| SCHEMBL8966981 | 0.86 | TSHR (0.38) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL21443951 | 0.84 | GAA (0.36) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL3841379 | 0.83 | TSHR (0.50) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL4075297 | 0.83 | MEN1 (0.37) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL21451457 | 0.82 | GAA (0.39) | TSHRMAPK1MEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2302015-B1 | OPTICALLY ISOTROPIC LIQUID CRYSTALLINE MEDIUM, AND OPTICAL ELEMENT | JNC CORP (JP) | 2016-10-05 | — | — | EP | disclosed |
| EP-2360229-B1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL ELEMENT | JNC CORP (JP) | 2016-08-31 | — | — | EP | disclosed |
| US-20130289316-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | JNC CORP (JP) | 2013-10-31 | — | — | US | disclosed |
| US-8501285-B2 | Optically isotropic liquid crystal medium and optical device | JNC CORPORATION (JP) | 2013-08-06 | — | — | US | disclosed |
| US-8475887-B2 | Optically isotropic liquid crystal medium, and optical device | JNC CORPORATION (JP) | 2013-07-02 | — | — | US | disclosed |
| US-8409673-B2 | Chlorobenzene derivative, optically isotropic liquid crystal medium, and optical device | JNC CORPORATION (JP) | 2013-04-02 | — | — | US | disclosed |
| US-20120099039-A1 | CHLOROBENZENE DERIVATIVE, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM, AND OPTICAL DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-04-26 | — | — | US | disclosed |
| EP-2433923-A1 | CHLOROBENZENE DERIVATIVE, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM, AND OPTICAL ELEMENT | JNC Corporation (JP) | 2012-03-28 | — | — | EP | disclosed |
| US-20110242473-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | JNC CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| EP-2360229-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL ELEMENT | JNC Corporation (JP) | 2011-08-24 | — | — | EP | disclosed |
| EP-2302015-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTALLINE MEDIUM, AND OPTICAL ELEMENT | Chisso Corporation (JP) | 2011-03-30 | — | — | EP | disclosed |
| US-20110069245-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTALLINE MEDIUM, AND OPTICAL ELEMENT | CHISSO PETROCHEMICAL CORPORATION (JP) | 2011-03-24 | — | — | US | disclosed |
| EP-0554005-B1 | Photopolymerisable components of radiation-sensitive compositions | AGFA GEVAERT NV (BE) | 2002-01-30 | — | — | EP | disclosed |
| EP-0554005-A1 | Photopolymerisable components of radiation-sensitive compositions | Du Pont (UK) Limited (GB) | 1993-08-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120099039-A1 | CHLOROBENZENE DERIVATIVE, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM, AND OPTICAL DEVICE | CRYAB, CYBA, CCNB1 | TSHR 4404/4885MAPK1 501/4885MEN1 4080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.